nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—CYP2C19—Sorafenib—thyroid cancer	0.0883	0.328	CbGbCtD
Formoterol—CYP2C9—Sorafenib—thyroid cancer	0.0734	0.272	CbGbCtD
Formoterol—CYP2D6—Sorafenib—thyroid cancer	0.0671	0.249	CbGbCtD
Formoterol—CYP2D6—Doxorubicin—thyroid cancer	0.0407	0.151	CbGbCtD
Formoterol—Dysphonia—Epirubicin—thyroid cancer	0.00233	0.00319	CcSEcCtD
Formoterol—Arrhythmia—Sorafenib—thyroid cancer	0.00233	0.00318	CcSEcCtD
Formoterol—Mental disorder—Sorafenib—thyroid cancer	0.00228	0.00312	CcSEcCtD
Formoterol—Malnutrition—Sorafenib—thyroid cancer	0.00227	0.0031	CcSEcCtD
Formoterol—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00224	0.00307	CcSEcCtD
Formoterol—Abscess—Doxorubicin—thyroid cancer	0.00224	0.00307	CcSEcCtD
Formoterol—Dysgeusia—Sorafenib—thyroid cancer	0.00222	0.00304	CcSEcCtD
Formoterol—Glycosuria—Doxorubicin—thyroid cancer	0.00219	0.003	CcSEcCtD
Formoterol—Muscle spasms—Sorafenib—thyroid cancer	0.00218	0.00298	CcSEcCtD
Formoterol—Injection site pain—Doxorubicin—thyroid cancer	0.00217	0.00297	CcSEcCtD
Formoterol—Abdominal pain—Vandetanib—thyroid cancer	0.00217	0.00297	CcSEcCtD
Formoterol—Body temperature increased—Vandetanib—thyroid cancer	0.00217	0.00297	CcSEcCtD
Formoterol—Dysphonia—Doxorubicin—thyroid cancer	0.00215	0.00295	CcSEcCtD
Formoterol—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.00212	0.0029	CcSEcCtD
Formoterol—Viral infection—Epirubicin—thyroid cancer	0.00212	0.0029	CcSEcCtD
Formoterol—Rectal haemorrhage—Epirubicin—thyroid cancer	0.00212	0.0029	CcSEcCtD
Formoterol—Skin discolouration—Epirubicin—thyroid cancer	0.00212	0.0029	CcSEcCtD
Formoterol—Bone disorder—Epirubicin—thyroid cancer	0.00212	0.0029	CcSEcCtD
Formoterol—Herpes simplex—Epirubicin—thyroid cancer	0.00208	0.00285	CcSEcCtD
Formoterol—Angioedema—Sorafenib—thyroid cancer	0.00207	0.00283	CcSEcCtD
Formoterol—Nocturia—Epirubicin—thyroid cancer	0.00207	0.00283	CcSEcCtD
Formoterol—Cough—Sorafenib—thyroid cancer	0.00198	0.00271	CcSEcCtD
Formoterol—Inflammation—Epirubicin—thyroid cancer	0.00198	0.0027	CcSEcCtD
Formoterol—Atrioventricular block—Epirubicin—thyroid cancer	0.00198	0.0027	CcSEcCtD
Formoterol—Asthenia—Vandetanib—thyroid cancer	0.00197	0.00269	CcSEcCtD
Formoterol—Skin discolouration—Doxorubicin—thyroid cancer	0.00196	0.00269	CcSEcCtD
Formoterol—Viral infection—Doxorubicin—thyroid cancer	0.00196	0.00269	CcSEcCtD
Formoterol—Bone disorder—Doxorubicin—thyroid cancer	0.00196	0.00269	CcSEcCtD
Formoterol—Rectal haemorrhage—Doxorubicin—thyroid cancer	0.00196	0.00269	CcSEcCtD
Formoterol—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.00196	0.00269	CcSEcCtD
Formoterol—Hypertension—Sorafenib—thyroid cancer	0.00196	0.00268	CcSEcCtD
Formoterol—Pruritus—Vandetanib—thyroid cancer	0.00194	0.00266	CcSEcCtD
Formoterol—Arthralgia—Sorafenib—thyroid cancer	0.00193	0.00264	CcSEcCtD
Formoterol—Myalgia—Sorafenib—thyroid cancer	0.00193	0.00264	CcSEcCtD
Formoterol—Herpes simplex—Doxorubicin—thyroid cancer	0.00192	0.00263	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00192	0.00262	CcSEcCtD
Formoterol—Nocturia—Doxorubicin—thyroid cancer	0.00191	0.00262	CcSEcCtD
Formoterol—Dermatitis contact—Epirubicin—thyroid cancer	0.00189	0.00259	CcSEcCtD
Formoterol—Dry mouth—Sorafenib—thyroid cancer	0.00189	0.00258	CcSEcCtD
Formoterol—Hyperkalaemia—Epirubicin—thyroid cancer	0.00188	0.00258	CcSEcCtD
Formoterol—Diarrhoea—Vandetanib—thyroid cancer	0.00188	0.00257	CcSEcCtD
Formoterol—Melaena—Epirubicin—thyroid cancer	0.00187	0.00256	CcSEcCtD
Formoterol—Cystitis noninfective—Epirubicin—thyroid cancer	0.00187	0.00256	CcSEcCtD
Formoterol—Cystitis—Epirubicin—thyroid cancer	0.00185	0.00253	CcSEcCtD
Formoterol—Anaphylactic shock—Sorafenib—thyroid cancer	0.00185	0.00253	CcSEcCtD
Formoterol—Infection—Sorafenib—thyroid cancer	0.00184	0.00252	CcSEcCtD
Formoterol—Candida infection—Epirubicin—thyroid cancer	0.00183	0.0025	CcSEcCtD
Formoterol—Inflammation—Doxorubicin—thyroid cancer	0.00183	0.0025	CcSEcCtD
Formoterol—Atrioventricular block—Doxorubicin—thyroid cancer	0.00183	0.0025	CcSEcCtD
Formoterol—Nervous system disorder—Sorafenib—thyroid cancer	0.00181	0.00248	CcSEcCtD
Formoterol—Dizziness—Vandetanib—thyroid cancer	0.00181	0.00248	CcSEcCtD
Formoterol—Skin disorder—Sorafenib—thyroid cancer	0.0018	0.00246	CcSEcCtD
Formoterol—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00176	0.00241	CcSEcCtD
Formoterol—Dermatitis contact—Doxorubicin—thyroid cancer	0.00175	0.0024	CcSEcCtD
Formoterol—Vomiting—Vandetanib—thyroid cancer	0.00174	0.00239	CcSEcCtD
Formoterol—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00174	0.00238	CcSEcCtD
Formoterol—Neoplasm—Epirubicin—thyroid cancer	0.00173	0.00237	CcSEcCtD
Formoterol—Bladder pain—Epirubicin—thyroid cancer	0.00173	0.00237	CcSEcCtD
Formoterol—Melaena—Doxorubicin—thyroid cancer	0.00173	0.00237	CcSEcCtD
Formoterol—Cystitis noninfective—Doxorubicin—thyroid cancer	0.00173	0.00237	CcSEcCtD
Formoterol—Rash—Vandetanib—thyroid cancer	0.00173	0.00237	CcSEcCtD
Formoterol—Dermatitis—Vandetanib—thyroid cancer	0.00173	0.00236	CcSEcCtD
Formoterol—Headache—Vandetanib—thyroid cancer	0.00172	0.00235	CcSEcCtD
Formoterol—Cystitis—Doxorubicin—thyroid cancer	0.00171	0.00234	CcSEcCtD
Formoterol—Candida infection—Doxorubicin—thyroid cancer	0.00169	0.00232	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00169	0.00231	CcSEcCtD
Formoterol—Abnormal vision—Epirubicin—thyroid cancer	0.00167	0.00229	CcSEcCtD
Formoterol—Dyspnoea—Sorafenib—thyroid cancer	0.00165	0.00226	CcSEcCtD
Formoterol—Nausea—Vandetanib—thyroid cancer	0.00163	0.00223	CcSEcCtD
Formoterol—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.00163	0.00223	CcSEcCtD
Formoterol—Dyspepsia—Sorafenib—thyroid cancer	0.00163	0.00223	CcSEcCtD
Formoterol—Bladder pain—Doxorubicin—thyroid cancer	0.0016	0.00219	CcSEcCtD
Formoterol—Neoplasm—Doxorubicin—thyroid cancer	0.0016	0.00219	CcSEcCtD
Formoterol—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.0016	0.00219	CcSEcCtD
Formoterol—Fatigue—Sorafenib—thyroid cancer	0.00159	0.00218	CcSEcCtD
Formoterol—Pain—Sorafenib—thyroid cancer	0.00158	0.00217	CcSEcCtD
Formoterol—Constipation—Sorafenib—thyroid cancer	0.00158	0.00217	CcSEcCtD
Formoterol—Abnormal vision—Doxorubicin—thyroid cancer	0.00155	0.00212	CcSEcCtD
Formoterol—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00153	0.0021	CcSEcCtD
Formoterol—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00151	0.00207	CcSEcCtD
Formoterol—Urticaria—Sorafenib—thyroid cancer	0.00147	0.00201	CcSEcCtD
Formoterol—Abdominal pain—Sorafenib—thyroid cancer	0.00146	0.002	CcSEcCtD
Formoterol—Body temperature increased—Sorafenib—thyroid cancer	0.00146	0.002	CcSEcCtD
Formoterol—Hypoglycaemia—Epirubicin—thyroid cancer	0.00143	0.00195	CcSEcCtD
Formoterol—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00142	0.00194	CcSEcCtD
Formoterol—Hypersensitivity—Sorafenib—thyroid cancer	0.00136	0.00187	CcSEcCtD
Formoterol—Asthenia—Sorafenib—thyroid cancer	0.00133	0.00182	CcSEcCtD
Formoterol—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00132	0.00181	CcSEcCtD
Formoterol—Pruritus—Sorafenib—thyroid cancer	0.00131	0.00179	CcSEcCtD
Formoterol—Dehydration—Epirubicin—thyroid cancer	0.00129	0.00177	CcSEcCtD
Formoterol—Dry skin—Epirubicin—thyroid cancer	0.00127	0.00175	CcSEcCtD
Formoterol—Hypokalaemia—Epirubicin—thyroid cancer	0.00127	0.00173	CcSEcCtD
Formoterol—Diarrhoea—Sorafenib—thyroid cancer	0.00127	0.00173	CcSEcCtD
Formoterol—Nasopharyngitis—Epirubicin—thyroid cancer	0.00124	0.0017	CcSEcCtD
Formoterol—Gastritis—Epirubicin—thyroid cancer	0.00123	0.00168	CcSEcCtD
Formoterol—Dizziness—Sorafenib—thyroid cancer	0.00122	0.00167	CcSEcCtD
Formoterol—Asthma—Epirubicin—thyroid cancer	0.0012	0.00165	CcSEcCtD
Formoterol—Influenza—Epirubicin—thyroid cancer	0.0012	0.00165	CcSEcCtD
Formoterol—Dehydration—Doxorubicin—thyroid cancer	0.0012	0.00164	CcSEcCtD
Formoterol—Dry skin—Doxorubicin—thyroid cancer	0.00118	0.00161	CcSEcCtD
Formoterol—Vomiting—Sorafenib—thyroid cancer	0.00118	0.00161	CcSEcCtD
Formoterol—Hypokalaemia—Doxorubicin—thyroid cancer	0.00117	0.0016	CcSEcCtD
Formoterol—Angina pectoris—Epirubicin—thyroid cancer	0.00117	0.0016	CcSEcCtD
Formoterol—Rash—Sorafenib—thyroid cancer	0.00117	0.0016	CcSEcCtD
Formoterol—Dermatitis—Sorafenib—thyroid cancer	0.00117	0.00159	CcSEcCtD
Formoterol—Headache—Sorafenib—thyroid cancer	0.00116	0.00159	CcSEcCtD
Formoterol—Bronchitis—Epirubicin—thyroid cancer	0.00116	0.00158	CcSEcCtD
Formoterol—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00115	0.00158	CcSEcCtD
Formoterol—Gastritis—Doxorubicin—thyroid cancer	0.00114	0.00156	CcSEcCtD
Formoterol—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00112	0.00153	CcSEcCtD
Formoterol—Asthma—Doxorubicin—thyroid cancer	0.00111	0.00152	CcSEcCtD
Formoterol—Influenza—Doxorubicin—thyroid cancer	0.00111	0.00152	CcSEcCtD
Formoterol—Nausea—Sorafenib—thyroid cancer	0.0011	0.0015	CcSEcCtD
Formoterol—Hyperglycaemia—Epirubicin—thyroid cancer	0.00108	0.00148	CcSEcCtD
Formoterol—Angina pectoris—Doxorubicin—thyroid cancer	0.00108	0.00148	CcSEcCtD
Formoterol—Bronchitis—Doxorubicin—thyroid cancer	0.00107	0.00146	CcSEcCtD
Formoterol—Urinary tract infection—Epirubicin—thyroid cancer	0.00104	0.00143	CcSEcCtD
Formoterol—Conjunctivitis—Epirubicin—thyroid cancer	0.00104	0.00143	CcSEcCtD
Formoterol—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00103	0.00142	CcSEcCtD
Formoterol—Haematuria—Epirubicin—thyroid cancer	0.00102	0.0014	CcSEcCtD
Formoterol—Sinusitis—Epirubicin—thyroid cancer	0.00101	0.00138	CcSEcCtD
Formoterol—Hyperglycaemia—Doxorubicin—thyroid cancer	0.001	0.00137	CcSEcCtD
Formoterol—Rhinitis—Epirubicin—thyroid cancer	0.000965	0.00132	CcSEcCtD
Formoterol—Conjunctivitis—Doxorubicin—thyroid cancer	0.000964	0.00132	CcSEcCtD
Formoterol—Urinary tract infection—Doxorubicin—thyroid cancer	0.000964	0.00132	CcSEcCtD
Formoterol—Pharyngitis—Epirubicin—thyroid cancer	0.000955	0.00131	CcSEcCtD
Formoterol—Urinary tract disorder—Epirubicin—thyroid cancer	0.00095	0.0013	CcSEcCtD
Formoterol—Oedema peripheral—Epirubicin—thyroid cancer	0.000948	0.0013	CcSEcCtD
Formoterol—Haematuria—Doxorubicin—thyroid cancer	0.000946	0.00129	CcSEcCtD
Formoterol—Connective tissue disorder—Epirubicin—thyroid cancer	0.000946	0.00129	CcSEcCtD
Formoterol—Urethral disorder—Epirubicin—thyroid cancer	0.000943	0.00129	CcSEcCtD
Formoterol—Sinusitis—Doxorubicin—thyroid cancer	0.00093	0.00127	CcSEcCtD
Formoterol—Visual impairment—Epirubicin—thyroid cancer	0.000927	0.00127	CcSEcCtD
Formoterol—Cardiac disorder—Epirubicin—thyroid cancer	0.000893	0.00122	CcSEcCtD
Formoterol—Rhinitis—Doxorubicin—thyroid cancer	0.000893	0.00122	CcSEcCtD
Formoterol—Pharyngitis—Doxorubicin—thyroid cancer	0.000884	0.00121	CcSEcCtD
Formoterol—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000879	0.0012	CcSEcCtD
Formoterol—Oedema peripheral—Doxorubicin—thyroid cancer	0.000877	0.0012	CcSEcCtD
Formoterol—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000875	0.0012	CcSEcCtD
Formoterol—Urethral disorder—Doxorubicin—thyroid cancer	0.000873	0.00119	CcSEcCtD
Formoterol—Immune system disorder—Epirubicin—thyroid cancer	0.000869	0.00119	CcSEcCtD
Formoterol—Mediastinal disorder—Epirubicin—thyroid cancer	0.000867	0.00119	CcSEcCtD
Formoterol—Arrhythmia—Epirubicin—thyroid cancer	0.00086	0.00118	CcSEcCtD
Formoterol—Visual impairment—Doxorubicin—thyroid cancer	0.000858	0.00117	CcSEcCtD
Formoterol—Mental disorder—Epirubicin—thyroid cancer	0.000843	0.00115	CcSEcCtD
Formoterol—Malnutrition—Epirubicin—thyroid cancer	0.000838	0.00115	CcSEcCtD
Formoterol—Cardiac disorder—Doxorubicin—thyroid cancer	0.000826	0.00113	CcSEcCtD
Formoterol—Tension—Epirubicin—thyroid cancer	0.000822	0.00113	CcSEcCtD
Formoterol—Dysgeusia—Epirubicin—thyroid cancer	0.00082	0.00112	CcSEcCtD
Formoterol—Nervousness—Epirubicin—thyroid cancer	0.000814	0.00111	CcSEcCtD
Formoterol—Back pain—Epirubicin—thyroid cancer	0.00081	0.00111	CcSEcCtD
Formoterol—Muscle spasms—Epirubicin—thyroid cancer	0.000805	0.0011	CcSEcCtD
Formoterol—Immune system disorder—Doxorubicin—thyroid cancer	0.000804	0.0011	CcSEcCtD
Formoterol—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000802	0.0011	CcSEcCtD
Formoterol—Arrhythmia—Doxorubicin—thyroid cancer	0.000795	0.00109	CcSEcCtD
Formoterol—Mental disorder—Doxorubicin—thyroid cancer	0.00078	0.00107	CcSEcCtD
Formoterol—Ill-defined disorder—Epirubicin—thyroid cancer	0.000777	0.00106	CcSEcCtD
Formoterol—Malnutrition—Doxorubicin—thyroid cancer	0.000775	0.00106	CcSEcCtD
Formoterol—Agitation—Epirubicin—thyroid cancer	0.00077	0.00105	CcSEcCtD
Formoterol—Tension—Doxorubicin—thyroid cancer	0.000761	0.00104	CcSEcCtD
Formoterol—Dysgeusia—Doxorubicin—thyroid cancer	0.000759	0.00104	CcSEcCtD
Formoterol—Malaise—Epirubicin—thyroid cancer	0.000755	0.00103	CcSEcCtD
Formoterol—Nervousness—Doxorubicin—thyroid cancer	0.000753	0.00103	CcSEcCtD
Formoterol—Back pain—Doxorubicin—thyroid cancer	0.00075	0.00103	CcSEcCtD
Formoterol—Muscle spasms—Doxorubicin—thyroid cancer	0.000745	0.00102	CcSEcCtD
Formoterol—Palpitations—Epirubicin—thyroid cancer	0.00074	0.00101	CcSEcCtD
Formoterol—Cough—Epirubicin—thyroid cancer	0.000731	0.001	CcSEcCtD
Formoterol—Hypertension—Epirubicin—thyroid cancer	0.000723	0.00099	CcSEcCtD
Formoterol—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000719	0.000984	CcSEcCtD
Formoterol—Chest pain—Epirubicin—thyroid cancer	0.000713	0.000976	CcSEcCtD
Formoterol—Myalgia—Epirubicin—thyroid cancer	0.000713	0.000976	CcSEcCtD
Formoterol—Arthralgia—Epirubicin—thyroid cancer	0.000713	0.000976	CcSEcCtD
Formoterol—Agitation—Doxorubicin—thyroid cancer	0.000712	0.000975	CcSEcCtD
Formoterol—Anxiety—Epirubicin—thyroid cancer	0.000711	0.000973	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000708	0.000969	CcSEcCtD
Formoterol—Discomfort—Epirubicin—thyroid cancer	0.000705	0.000964	CcSEcCtD
Formoterol—Malaise—Doxorubicin—thyroid cancer	0.000699	0.000957	CcSEcCtD
Formoterol—Dry mouth—Epirubicin—thyroid cancer	0.000697	0.000955	CcSEcCtD
Formoterol—Palpitations—Doxorubicin—thyroid cancer	0.000685	0.000937	CcSEcCtD
Formoterol—Anaphylactic shock—Epirubicin—thyroid cancer	0.000684	0.000936	CcSEcCtD
Formoterol—Oedema—Epirubicin—thyroid cancer	0.000684	0.000936	CcSEcCtD
Formoterol—Infection—Epirubicin—thyroid cancer	0.000679	0.00093	CcSEcCtD
Formoterol—Cough—Doxorubicin—thyroid cancer	0.000676	0.000926	CcSEcCtD
Formoterol—Nervous system disorder—Epirubicin—thyroid cancer	0.00067	0.000918	CcSEcCtD
Formoterol—Hypertension—Doxorubicin—thyroid cancer	0.000669	0.000916	CcSEcCtD
Formoterol—Tachycardia—Epirubicin—thyroid cancer	0.000667	0.000913	CcSEcCtD
Formoterol—Skin disorder—Epirubicin—thyroid cancer	0.000664	0.000909	CcSEcCtD
Formoterol—Chest pain—Doxorubicin—thyroid cancer	0.00066	0.000903	CcSEcCtD
Formoterol—Myalgia—Doxorubicin—thyroid cancer	0.00066	0.000903	CcSEcCtD
Formoterol—Arthralgia—Doxorubicin—thyroid cancer	0.00066	0.000903	CcSEcCtD
Formoterol—Anxiety—Doxorubicin—thyroid cancer	0.000658	0.0009	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000655	0.000897	CcSEcCtD
Formoterol—Discomfort—Doxorubicin—thyroid cancer	0.000652	0.000892	CcSEcCtD
Formoterol—Dry mouth—Doxorubicin—thyroid cancer	0.000645	0.000883	CcSEcCtD
Formoterol—Hypotension—Epirubicin—thyroid cancer	0.000639	0.000874	CcSEcCtD
Formoterol—Oedema—Doxorubicin—thyroid cancer	0.000633	0.000866	CcSEcCtD
Formoterol—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000633	0.000866	CcSEcCtD
Formoterol—Infection—Doxorubicin—thyroid cancer	0.000628	0.00086	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000623	0.000853	CcSEcCtD
Formoterol—Nervous system disorder—Doxorubicin—thyroid cancer	0.00062	0.000849	CcSEcCtD
Formoterol—Insomnia—Epirubicin—thyroid cancer	0.000618	0.000846	CcSEcCtD
Formoterol—Tachycardia—Doxorubicin—thyroid cancer	0.000617	0.000845	CcSEcCtD
Formoterol—Skin disorder—Doxorubicin—thyroid cancer	0.000614	0.000841	CcSEcCtD
Formoterol—Dyspnoea—Epirubicin—thyroid cancer	0.000609	0.000834	CcSEcCtD
Formoterol—Somnolence—Epirubicin—thyroid cancer	0.000608	0.000832	CcSEcCtD
Formoterol—Dyspepsia—Epirubicin—thyroid cancer	0.000602	0.000824	CcSEcCtD
Formoterol—Hypotension—Doxorubicin—thyroid cancer	0.000591	0.000809	CcSEcCtD
Formoterol—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00059	0.000808	CcSEcCtD
Formoterol—Fatigue—Epirubicin—thyroid cancer	0.000589	0.000807	CcSEcCtD
Formoterol—Constipation—Epirubicin—thyroid cancer	0.000585	0.0008	CcSEcCtD
Formoterol—Pain—Epirubicin—thyroid cancer	0.000585	0.0008	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000576	0.000789	CcSEcCtD
Formoterol—Insomnia—Doxorubicin—thyroid cancer	0.000572	0.000783	CcSEcCtD
Formoterol—Dyspnoea—Doxorubicin—thyroid cancer	0.000564	0.000772	CcSEcCtD
Formoterol—Feeling abnormal—Epirubicin—thyroid cancer	0.000563	0.000771	CcSEcCtD
Formoterol—Somnolence—Doxorubicin—thyroid cancer	0.000562	0.00077	CcSEcCtD
Formoterol—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000559	0.000765	CcSEcCtD
Formoterol—Dyspepsia—Doxorubicin—thyroid cancer	0.000557	0.000762	CcSEcCtD
Formoterol—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000546	0.000747	CcSEcCtD
Formoterol—Fatigue—Doxorubicin—thyroid cancer	0.000545	0.000746	CcSEcCtD
Formoterol—Urticaria—Epirubicin—thyroid cancer	0.000543	0.000743	CcSEcCtD
Formoterol—Constipation—Doxorubicin—thyroid cancer	0.000541	0.00074	CcSEcCtD
Formoterol—Pain—Doxorubicin—thyroid cancer	0.000541	0.00074	CcSEcCtD
Formoterol—Abdominal pain—Epirubicin—thyroid cancer	0.00054	0.00074	CcSEcCtD
Formoterol—Body temperature increased—Epirubicin—thyroid cancer	0.00054	0.00074	CcSEcCtD
Formoterol—Feeling abnormal—Doxorubicin—thyroid cancer	0.000521	0.000713	CcSEcCtD
Formoterol—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000517	0.000708	CcSEcCtD
Formoterol—Hypersensitivity—Epirubicin—thyroid cancer	0.000504	0.000689	CcSEcCtD
Formoterol—Urticaria—Doxorubicin—thyroid cancer	0.000502	0.000688	CcSEcCtD
Formoterol—Body temperature increased—Doxorubicin—thyroid cancer	0.0005	0.000684	CcSEcCtD
Formoterol—Abdominal pain—Doxorubicin—thyroid cancer	0.0005	0.000684	CcSEcCtD
Formoterol—Asthenia—Epirubicin—thyroid cancer	0.00049	0.000671	CcSEcCtD
Formoterol—Pruritus—Epirubicin—thyroid cancer	0.000484	0.000662	CcSEcCtD
Formoterol—Diarrhoea—Epirubicin—thyroid cancer	0.000468	0.00064	CcSEcCtD
Formoterol—Hypersensitivity—Doxorubicin—thyroid cancer	0.000466	0.000638	CcSEcCtD
Formoterol—Asthenia—Doxorubicin—thyroid cancer	0.000454	0.000621	CcSEcCtD
Formoterol—Dizziness—Epirubicin—thyroid cancer	0.000452	0.000619	CcSEcCtD
Formoterol—Pruritus—Doxorubicin—thyroid cancer	0.000448	0.000613	CcSEcCtD
Formoterol—Vomiting—Epirubicin—thyroid cancer	0.000435	0.000595	CcSEcCtD
Formoterol—Diarrhoea—Doxorubicin—thyroid cancer	0.000433	0.000592	CcSEcCtD
Formoterol—Rash—Epirubicin—thyroid cancer	0.000431	0.00059	CcSEcCtD
Formoterol—Dermatitis—Epirubicin—thyroid cancer	0.000431	0.000589	CcSEcCtD
Formoterol—Headache—Epirubicin—thyroid cancer	0.000428	0.000586	CcSEcCtD
Formoterol—Dizziness—Doxorubicin—thyroid cancer	0.000418	0.000573	CcSEcCtD
Formoterol—Nausea—Epirubicin—thyroid cancer	0.000406	0.000556	CcSEcCtD
Formoterol—Vomiting—Doxorubicin—thyroid cancer	0.000402	0.00055	CcSEcCtD
Formoterol—Rash—Doxorubicin—thyroid cancer	0.000399	0.000546	CcSEcCtD
Formoterol—Dermatitis—Doxorubicin—thyroid cancer	0.000398	0.000545	CcSEcCtD
Formoterol—Headache—Doxorubicin—thyroid cancer	0.000396	0.000542	CcSEcCtD
Formoterol—Nausea—Doxorubicin—thyroid cancer	0.000376	0.000514	CcSEcCtD
